Ligation of protease-activated receptor 1 enhances αv β6 integrin–dependent TGF-β activation and promotes acute lung injury
J. Clin. Invest. R. Gisli Jenkins, et al. 116:1606
doi:10.1172/JCI27183 [Go to this article.]

Figure 5
PAR1 signals via RhoA and Rho kinase to induce αv β6 -mediated TGF-β activation. (A) WT mouse embryonic fibroblasts expressing αvβ6 (MEFβ6) were adenovirally infected with GFP, constitutively active (CA) RhoA, or dominant-negative (DN) RhoA. After infection and cell sorting, cells were stimulated (white bars) or were not stimulated (black bars) with 10 μM SFLLRN, and β6-dependent TGF-β activity was calculated from coculture bioassays with TML cells. Unstimulated Par1–/– cells expressing αvβ6 were also infected with an adenovirus encoding a constitutively active RhoA, dominant-negative RhoA, or GFP control and studied in coculture bioassays, as above. (B) IMLE cells and mouse embryonic fibroblasts, both expressing the β6 integrin, were stimulated with 10 μM SFLLRN (dashed lines) in the presence of increasing doses of the Rho kinase inhibitor Y-27632, and αvβ6-mediated TGF-β activity was compared with that of unstimulated IMLE cells (solid lines). (C) MEFβ6 cells were stimulated with 10 μM SFLLRN or 500 pg/ml TGF-β for 4 hours in the presence or absence of the Rho kinase inhibitor Y-27632 and an αvβ6 blocking antibody, and compared with unstimulated cells. Cell lysates were analyzed by Western blotting for phospho-Smad2 or total Smad2. All results are representative of at least 3 independent experiments. *P < 0.005.